With a rare blend of clinical depth and technical vision, Frank leads Compass Bioinformatics as CEO – bringing together a global team of AI engineers, software developers, and genetics professionals to build cutting-edge platforms for analyzing next-generation sequencing data in rare and inherited diseases. His leadership spans top roles at Prenetics, ACT Genomics, Everly Health, Illumina, QIAGEN, and Roche. A physician-scientist by training, Frank completed his Clinical Molecular Genetics fellowship at UCLA, holds an MD from USC, and trained in biodesign at Stanford. Frank’s mission is bold but clear: to transform patient care through AI-driven, privacy-conscious bioinformatics. Here’s what our advisors Gregory & Heath say about him: “Frank has broad experience in healthcare with a particularly deep focus on applying cutting edge technologies to real clinical issues… Frank has a great combination of knowing what’s right for the patient and what’s right for the business.” “Frank is a rare blend of physician-scientist, innovator, and leader—equally fluent in clinical medicine, molecular genetics, and AI-driven bioinformatics. He has a gift for translating complex science into practical, high-impact solutions, especially in genomics and precision medicine. As a leader, Frank has deep expertise yet remains grounded, able to align cross-functionally and drive execution across disciplines and continents.“ Now, under his leadership, Compass Bioinformatics is delivering smarter, faster, and more impactful genomic solutions to the world.